Product Description

A broad-spectrum fluoroquinolone indicated for the management in diseases in dogs and cats associated with bacteria susceptible to enrofloxacin. It has activity against both Gram-negative and Gram-positive bacteria, including those causing dermal, urinary, and respiratory tract infections.

Features & Benefits

• Synthetic chemotherapeutic agent from the class of quinolone carboxylic acid derivatives
• Antibacterial activity against a broad spectrum of gram negative and gram positive bacteria
• Rapidly absorbed from the digestive tract, penetrating into all measured body tissues and fluids
• Beef flavored double-scored chewable tablets
• Available in 22.7 mg, 68 mg and 136 mg tablets